REICH KRISTIAN (Chief Scientific Officer) sold 1.9% of their position (52.45K shares) of MOONLAKE IMMUNOTHERAPEUTICS on the open market
Open‑market sale worth $1.05M — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/23/2026ACC: 0001213900-26-080869
Officer· Chief Scientific Officer
Since Apr 2022
-52.45K
Net shares
Net seller
$1.05M
Total sold
2
Open market trades
0B · 2S
2
Total transactions
52.45K disposed
Non-Derivative Transactions2
Class A ordinary shares, par value $0.0001 per share
Indirect
Shares
−50K
Price / share
$20.02
Trade value
$1M
% of position
1.8%
7/21/2026
2.76M→2.71M
Class A ordinary shares, par value $0.0001 per share
Indirect
Shares
−2.45K
Price / share
$20.00
Trade value
$48.96K
% of position
0.1%
7/22/2026
2.71M→2.71M
Total
Net shares
−52.45K
Net value
-$1.05M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A ordinary shares, par value $0.0001 per share Indirect | 7/21/2026 | S · Sale | −50K | $20.02 | $1M | 1.8% | 2.76M | 2.71M |
| Class A ordinary shares, par value $0.0001 per share Indirect | 7/22/2026 | S · Sale | −2.45K | $20.00 | $48.96K | 0.1% | 2.71M | 2.71M |
| Total | −52.45K | -$1.05M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Class A ordinary shares, par value $0.0001 per share
DirectShares owned35.39K
Total
35.39K direct35.39K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Class A ordinary shares, par value $0.0001 per share | 35.39K | Direct |
| Total | 35.39K | 35.39K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported